Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Intranasal Oxytocin in Benzodiazepine Withdrawal
NCT06757517Phase 2Completed
- Sponsor
- St. Olavs University Hospital
- Start
- Mar 2022
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in benzodiazepine dependence, sponsored by St. Olavs University Hospital. Started Mar 2022; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
benzodiazepine dependence
Beyond the preview
Go deeper on NCT06757517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06757517.